Mitchell KB, Kuerer H (2015) Ductal carcinoma in situ: treatment update and current trends. Curr Oncol Rep 17:48. https://doi.org/10.1007/s11912-015-0473-x

Article  PubMed  Google Scholar 

Nash AL, Hwang ES (2023) The landmark series—ductal carcinoma in situ: the evolution of treatment. Ann Surg Oncol 30:3206–3214. https://doi.org/10.1245/s10434-023-13370-1

Article  PubMed  Google Scholar 

Fisher B, Dignam J, Wolmark N, Mamounas E, Costantino J, Poller W, Fisher ER, Wickerham DL, Deutsch M, Margolese R, Dimitrov N, Kavanah M (1998) Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol 16(2):441–452. https://doi.org/10.1200/JCO.1998.16.2.441

Article  CAS  PubMed  Google Scholar 

Fisher B, Dignam J, Wolmark N, Wickerham DL, Fisher ER, Mamounas E, Smith R, Begovic M, Dimitrov NV, Margolese RG, Kardinal CG, Kavanah MT, Fehrenbacher L, Oishi RH (1999) Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial. The Lancet 353(9169):1993–2000. https://doi.org/10.1016/S0140-6736(99)05036-9

Article  CAS  Google Scholar 

Wärnberg F, Garmo H, Emdin S, Hedberg V, Adwall L, Sandelin K, Ringberg A, Karlsson P, Arnesson LG, Anderson H, Jirström K, Holmberg L (2014) Effect of radiotherapy after breast-conserving surgery for ductal carcinoma in situ: 20 years follow-up in the randomized SweDCIS Trial. J Clin Oncol 10(32):3613–3618. https://doi.org/10.1200/JCO.2014.56.2595

Article  Google Scholar 

Julien JP, Bijker N, Fentiman IS, Peterse JL, Delledonne V, Rouanet P, Avril A, Sylvester R, Mignolet F, Bartelink H, Van Dongen JA (2000) Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853. EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. The Lancet 355(9203):528–533. https://doi.org/10.1016/s0140-6736(99)06341-2

Article  CAS  Google Scholar 

Cuzick J, Sestak I, Pinder SE, Elis IO, Forsyth S, Bundred NJ, Forbes JF, Bishop H, Fentiman IS, George WD (2011) Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: longterm results from UK/ANZ DCIS trial. Lancet Oncol 12(1):21–29. https://doi.org/10.1016/S1470-2045(10)70266-7

Article  CAS  PubMed  Google Scholar 

McCormick B, Winter KA, Woodward W, Kuerer HM, Sneige N, Rakovitch E, Smith BL, Germain I, Hartford AC, O’Rourke MA, Walker EM, Strom EA, Hopkins JO, Pierce LJ, Pu AT, Sumida KNM, Vesprini D, Moughan J, White JR (2021) Randomized phase III trial evaluating radiation following surgical excision for good-risk ductal carcinoma in situ: long-term report from NRG Oncology/RTOG 9804. J Clin Oncol 39(32):3574–3582. https://doi.org/10.1200/JCO.21.01083

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wapnir IL, Dignam JJ, Fisher B, Mamounas EP, Anderson SJ, Julian TB, Land SR, Margolese RG, Swain SM, Costantino JP, Wolmark N (2011) Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. J Natl Cancer Inst 103(6):478–488. https://doi.org/10.1093/jnci/djr027

Article  PubMed  PubMed Central  Google Scholar 

Mammary Fold Academic Research Collaborative (2016) Variation in the management of ductal carcinoma in situ in the UK: results of the mammary fold national practice survey. Eur J Surg Oncol 42(8):1153–1161

Article  Google Scholar 

Seguin R, Peiris L (2021) National variations in the work-up, investigation, and surgical management of ductal carcinoma in situ of the breast across Canadian surgeons. Curr Oncol 28(2):1366–1375

Article  PubMed  PubMed Central  Google Scholar 

Kaufman SA, Harris EE, Bailey L et al (2015) ACR appropriateness criteria® ductal carcinoma in situ. Oncology 29(6):446–458

PubMed  Google Scholar 

Hamilton SN, Nichol A, Wai E, Gondara L, Velásquez García HA, Speers C, Diocee R, Truong P (2019) Local relapse after breast-conserving therapy versus mastectomy for extensive pure ductal carcinoma in situ ≥4 cm. Int J Radiat Oncol Biol Phys 103(2):381–388. https://doi.org/10.1016/j.ijrobp.2018.09.022

Article  PubMed  Google Scholar 

National Comprehensive Cancer Network (NCCN) clinical practice guidelines in oncology (NCCN Guidelines®) for breast cancer, version 6.2024

Morrow M, Van Zee KJ, Solin LJ, Houssami N, Chavez-MacGregor M, Harris JR, Horton J, Hwang S, Johnson PL, Marinovich ML, Schnitt SJ, Wapnir I, Moran MS (2016) Society of Surgical Oncology-American Society for Radiation Oncology-American Society of Clinical Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in ductal carcinoma in situ. J Clin Oncol 34(33):4040–4046. https://doi.org/10.1200/JCO.2016.68.3573

Article  PubMed  PubMed Central  Google Scholar 

Schmitz RSJM, van den Belt-Dusebout AW, Clements K, Ren Y, Cresta C, Timbres J, Liu YH, Byng D, Lynch T, Menegaz BA, Collyar D, Hyslop T, Thomas S, Love JK, Schaapveld M, Bhattacharjee P, Ryser MD, Sawyer E, Hwang ES, Thompson A, Wesseling J, Lips EH, Schmidt MK, Grand Challenge PRECISION consortium (2023) Association of DCIS size and margin status with risk of developing breast cancer post-treatment: multinational, pooled cohort study. BMJ 383:e076022. https://doi.org/10.1136/bmj-2023-076022

Article  PubMed  PubMed Central  Google Scholar 

Rodin D, Sutradhar R, Nofech-Mozes S, Gu S, Faught N, Hahn E, Fong C, Trebinjac S, Paszat L, Rakovitch E (2022) Long-term outcomes of women with large DCIS lesions treated with breast-conserving therapy. Breast Cancer Res Treat 192(1):223–233. https://doi.org/10.1007/s10549-021-06488-x

Article  PubMed  Google Scholar 

Ryan JF, Lesniak DM, Cordeiro E et al (2023) Surgeon factors influencing breast surgery outcomes: a scoping review to define the modern breast surgical oncologist. Ann Surg Oncol 30:4695–4713. https://doi.org/10.1245/s10434-023-13472-w

Article  PubMed  Google Scholar 

Munshi A, Kakkar S, Bhutani R, Jalali R, Budrukkar A, Dinshaw KA (2009) Factors influencing cosmetic outcome in breast conservation. Clin Oncol (R Coll Radiol) 21(4):285–293. https://doi.org/10.1016/j.clon.2009.02.001

Article  CAS  PubMed  Google Scholar 

Dicks E, Roome R, Chafe J, Powell E, McCrate F, Simmonds C, Etchegary H (2019) Factors influencing surgical treatment decisions for breast cancer: a qualitative exploration of surgeon and patient perspectives. Curr Oncol 26(2):216–225. https://doi.org/10.3747/co.26.4305

Article  Google Scholar 

Elshof LE, Tryfonidis K, Slaets L, van Leeuwen-Stok AE, Skinner VP, Dif N, Pijnappel RM, Bijker N, Rutgers EJ, Wesseling J (2015) Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ—the LORD study. Eur J Cancer 51(12):1497–1510. https://doi.org/10.1016/j.ejca.2015.05.008

Article  PubMed  Google Scholar 

Schmitz RSJM, Engelhardt EG, Gerritsma MA, Sondermeijer CMT, Verschuur E, Houtzager J, Griffioen R, Retèl V, Bijker N, Mann RM, van Duijnhoven F, Wesseling J, Bleiker EMA, Grand Challenge PRECISION Consortium (2023) Active surveillance versus treatment in low-risk DCIS: women’s preferences in the LORD-trial. Eur J Cancer 192:113276. https://doi.org/10.1016/j.ejca.2023.113276

Article  PubMed  Google Scholar 

Francis A, Thomas J, Fallowfield L, Wallis M, Bartlett JM, Brookes C, Roberts T, Pirrie S, Gaunt C, Young J, Billingham L, Dodwell D, Hanby A, Pinder SE, Evans A, Reed M, Jenkins V, Matthews L, Wilcox M, Fairbrother P, Bowden S, Rea D (2015) Addressing overtreatment of screen detected DCIS; the LORIS trial. Eur J Cancer 51(16):2296–2303. https://doi.org/10.1016/j.ejca.2015.07.017

Article  PubMed  Google Scholar 

Hwang ES, Hyslop T, Lynch T, Frank E, Pinto D, Basila D, Collyar D, Bennett A, Kaplan C, Rosenberg S, Thompson A, Weiss A, Partridge A (2019) The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS). BMJ Open 9(3):e026797. https://doi.org/10.1136/bmjopen-2018-026797

Article  PubMed  PubMed Central  Google Scholar